Europe Breast Pumps Market to Mark a Highest CAGR of 7.9% Through 2025: Grand View Research Inc.

San Francisco, 1 March 2019: The Report Europe Breast Pumps Market Size, Share & Trends Analysis Report By Product (Open, Closed), By Technology (Manual, Electric), By Application (Personal, Hospital), And Regional Segment Forecasts, 2019 - 2025

The Europe breast pumps market size is expected to reach USD 676.53 million by 2025, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 7.9% during the forecast period. Increasing women employment, government initiatives aimed at improving consumer awareness, and improving healthcare infrastructure in emerging economies are the key driving factors.

Europe breast pumps market in developed economies, such as Germany, France, and Poland is saturated owing to increasing demand and presence of key market players. Economic development and rising disposable income are anticipated to help driving future sustainability for the regional market. Manufacturers investing in these rapidly developing markets are expected to witness high growth, provided pricing and distribution activities are undertaken effectively.

The end users in the Europe breast pump market, i.e. the lactating mothers, are becoming increasingly aware about the benefits and importance of breastfeeding. Increase in women employment and neonatal mortality rate is driving the adoption of advanced medical technologies in everyday lives of the consumers in this region. For instance, as per Global Economy, women employment rate in Germany increased from 54.51% in 2014 to 55.03% in 2017. Women in developed countries such as Germany and Poland are using technologically advanced devices in their everyday lives to reduce the time spent on routine activities. Such factors are anticipated to drive the regional market.

Access Research Report of Europe Breast Pumps Market @ www.grandviewresearch.com/industry-analysis/europe-breast-pumps-market

Further key findings from the report suggest:

·       In terms of revenue, closed system segment is projected to ascend at the fastest CAGR over the forecast period. Ease of usage and better safety than the open system breast pumps can be attributed to the segment growth

·       Electric breast pumps commanded the highest market share in 2017 and is expected to witness the fastest growth over the forecast period owing to the increase in inclination towards technologically advanced products

·       Hospital grade breast pumps are expected to witness the fastest growth owing to the rising awareness regarding the benefit of breastfeeding and high employment rate among women

·       Some of the key companies present in the Europe breast pumps market are Ameda; Energizer Holdings, Inc.; Medela AG; Koninklijke Philips N.V.; Büttner-Frank GmbH; and Pigeon Corporation.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Europe breast pumps market on the basis of product, technology, application, and region:

Europe Breast Pump Product Outlook (Volume, Units; Revenue USD Million, 2014 - 2025)

·         Open System

·         Closed System

Europe Breast Pump Technology Outlook (Volume, Units; Revenue USD Million, 2014 - 2025)

·         Manual

·         Battery Powered

·         Electric

Europe Breast Pump Application Outlook (Volume, Units; Revenue USD Million, 2014 - 2025)

·         Personal Use

·         Hospital Grade

Europe Breast Pump Country Outlook (Volume, Units; Revenue USD Million, 2014 - 2025)

·         Greece

·         Italy

·         Germany

·         Poland

·         France

Access Press Release of Europe Breast Pumps Market@ www.grandviewresearch.com/press-release/europe-breast-pumps-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Anti-Snoring Devices & Snoring Surgery Market is Projected to Boost USD 1.84 Billion by 2024: Grand View Research Inc.

San Francisco, 1 March 2019: The Report Anti-Snoring Devices And Snoring Surgery Market By Device Type (Oral, Nasal Dilator, Chin Strap, Position Control, Tongue Stabilizing Devices, Expiratory Positive Airway Pressure), By Surgical Procedure (Uvulopalatopharyngoplasty, Laser-Assisted Uvulopalatoplasty, Radiofrequency Ablation, Sclerotherapy, Pillar Procedure, Septoplasty, Palatal Stiffening Procedures),By Region (U.S., Canada, Germany, UK, China, India, South Africa, Brazil, Mexico) And Segment Forecast To 2024

Global anti-snoring devices and snoring surgery market is expected to reach USD 1.84 billion by 2024, according to a new report by Grand View Research, Inc. The anti-snoring devices and snoring surgery market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing awareness levels about the ill effects of snoring, rising elderly and obese population, the presence of an unexploited consumer base, and the increasing consumption of alcohol and cigarettes. However, factors such as the cost prohibitive nature of the products, limited efficacy of the presently available treatments, and the presence of an unpropitious reimbursement scenario are likely to hinder the growth of the market.

The market is segmented into anti-snoring devices and snoring surgery segments. The anti-snoring devices segment includes oral appliances, nasal devices, position control devices, chin straps, tongue stabilizing devices, and expiratory positive airway pressure therapy devices. The surgery segment includes uvulopalatopharyngoplasty, laser-assisted uvulopalatoplasty, radiofrequency ablation, sclerotherapy, pillar procedure, and others. North America and Europe are the major shareholders of this industry due mainly to the increasing awareness associated with available treatment options and the eventual rise in popularity and adoption of these products. The Asia Pacific region is expected to witness high growth as a consequence of the untapped population base characterized with a snoring condition, higher levels of awareness regarding the effects of snoring, and the presence of well-established players in the sector. 

Access Research Report of Anti-Snoring Devices & Snoring Surgery Market @ www.grandviewresearch.com/industry-analysis/anti-snoring-devices-snoring-surgery-market

Further key findings from the study suggest:

·       North America is estimated to lead the industry with the largest market share in 2015.This growth is attributed to the rapidly increasing popularity and the resultant high market penetration of such treatment devices. Asia Pacific is expected to exhibit the highest growth rate owing to the large untreated population and the rising awareness levels with regard to treatment options and the notorious health consequences associated with this condition.

·       In surgery, somnoplasty is estimated to be the fastest growing segment due largely to factors, such as low cost, reduced surgical trauma, less invasive, and chances of fewer complications in comparison to the traditional surgery procedures

·       The anti-snoring devices and snoring surgery market comprises several local as well as global players. Some key market players include Tomed Dr. Toussaint GmbH, Apnea Sciences Corporation, and Meditas Ltd., among others. The companies have adopted several organic and inorganic strategies in order to gain prominence in this sector. A few of these strategies include geographic expansion, new product launches, new product development, partnerships, collaborations, and mergers and acquisitions, among others. For instance, in March 2015, Meditas Ltd. launched nasal dilators for uninterrupted flow of air. 

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global anti-snoring devices and snoring surgery market on the basis of type and region:

Anti-Snoring Devices Type Outlook (Revenue, USD Million, 2013 - 2024)

·         Oral

·         Nasal Dilator

·         Chin Strap

·         Position Control

·         Tongue Stabilizing Devices

·         Expiratory Positive Airway Pressure

Snoring Surgical Procedure Outlook (Revenue, USD Million, 2013 - 2024)

·         Uvulopalatopharyngoplasty

·         Laser-Assisted Uvulopalatoplasty

·         Radiofrequency Ablation

·         Sclerotherapy

·         Pillar Procedure

·         Septoplasty

·         Palatal Stiffening Procedures

·         Other anti-snoring surgical procedures 

Anti-Snoring Devices And Snoring Surgery Regional Outlook (Revenue, USD Million, 2013 - 2024)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         MEA

Access Press Release of Anti-Snoring Devices & Snoring Surgery Market@ www.grandviewresearch.com/press-release/global-anti-snoring-devices-snoring-surgery-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Mixed Tocopherols Market to Raise at CAGR of 2.4% from 2017 to 2025: Grand View Research Inc.

San Francisco, 1 March 2019: The Report Mixed Tocopherols Market Analysis By Product (Alpha Rich, Gamma Rich, Gamma-Delta Rich), By Application (Dietary Supplements, Cosmetics, Pharmaceuticals), And Segment Forecasts, 2018 - 2025

The global mixed tocopherols market is expected to reach USD 11.94billion by 2025, according to a new report by Grand View Research, Inc.Rising vitamin E demand in food and dietary supplements owing to rising health concerns is expected to plays a significant role in promoting the industry growth over the next few years. The global market is anticipated to observe sluggish growth at a CAGR of 2.4% from 2017 to 2025.

Alpha rich tocopherols was the leading product segment and is anticipated to grow at a CAGR of 2.3%, by revenue, over the forecast period. The segment is expected to gain share over the forecast period owing to high demand in dietary supplements. Health benefits associated with vitamin E to treat deficiency and diseases such as lung, oral, colorectal and pancreatic cancer; polyps, and gastric are also anticipated to drive the mixed tocopherols market in pharmaceuticals over the forecast period.

Access Research Report of Mixed Tocopherols Market @ www.grandviewresearch.com/industry-analysis/mixed-tocopherols-industry

Further key findings from the reportsuggest:

·       The global mixed tocopherols demand was117.8 kilo tons in 2016 and is estimated to grow at a CAGR of 3.6% from 2017 to 2025

·       Mixed tocopherols demand in dietary supplements was 50.9 kilo tons in 2016 and is anticipated to witness moderate growth over the next eight years

·       Product demand in animal feed nutritionis anticipated to emerge as the fastest growing application segment, and generate revenues worth over USD 2 billion by 2025

·       Mixed tocopherolsindustry valuation in North America is projected to reach USD 3.60 billion by 2025 and is estimated to grow as a significant rate from 2017 to 2025

·       The U.S. gamma rich tocopherols demand is anticipated to emerge as the fastest growing market in North America and is expected to reach total volume of over 5.6 kilo tons by 2025

·       The industry in Europeis projected to witness moderate growth of 2.9% from 2017 to 2025 owing to the increased use of mixed tocopherols as antioxidants and feed additives

·       Asia Pacific was the dominant consumer in 2016. High rate of dietary supplements, animal feed, and pharmaceuticals manufacturing in key economies including China, Japan, and India is the major factor for industry penetration.

·       Key industry participants such asBASF, DSM, ADM,and Cargill dominated the global mixed tocopherol market over the next few years. The major players operating in the mixed tocopherol market comprise, BTSA, Vitae Naturals, Zhejiang Medicine Co., Ltd. (ZMC), COFCO Tech Bioengineering Co., Ltd., Eisai Food & Chemical Co., Ltd., and Vance Group Ltd.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/food-additives-nutricosmetics-flavors-and-fragrances

Grand View Research has segmented the global mixed tocopherolsmarket on the basis of product, application, and region:

Product Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

·         Alpha Rich

·         Gamma Rich

·         Gamma-Delta Rich

·         Others

Application Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

·         Dietary Supplements

·         Animal Feed Nutrition

·         Cosmetics

·         Pharmaceuticals

·         Food & Beverage Fortification

Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Central & South America

·         Middle East & Africa 

Access Press Release of Mixed Tocopherols Market@ www.grandviewresearch.com/press-release/global-mixed-tocopherols-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Empty Capsules Market Analysis By Leading Players, Current Trends & Predictions by 2024: Grand View Research Inc.

San Francisco, 1 March 2019: The Report Empty Capsules Market Analysis By Product (Gelatin, Non-Gelatin Capsules), By Therapeutic Application (Antibiotic & Antibacterial Drugs, Vitamin & Dietary Supplements, Antacids & Anti-flatulent Preparations, Anti-anemic Preparations, Anti-Inflammatory & Anti-rheumatic Drugs, Cardiac Therapy Drugs, Cough & Cold Preparations), By End-user(Pharmaceutical, Nutraceutical, Cosmetics Industries, Research laboratories) And Segment Forecasts To 2024

The global empty capsules market is expected to reach USD 2.57 billion by 2024, according to a new report by Grand View Research, Inc. Key factors responsible for the growth are the increase in the geriatric population, proliferation of pharmaceutical, nutraceutical, and cosmeceutical industries, globally and the upsurge in the consumer preferences for capsules over tablets. 

The rising geriatric population count and the associated chronic conditions are expected to heighten the demand for the production of capsule-centric medications in the pharmaceutical and nutraceutical application areas. Moreover, the benefits associated with capsule consumption, such as ease of swallowing, faster absorption rates, and increased palatability are also expected to contribute significantly to the expansion of the market over the forecast period. 

The mushrooming of the pharmaceutical, nutraceutical, and cosmeceutical industries is expected to serve as a high impact rendering driver for the empty capsules market over the forecast period. 

The nutraceuticals aid in the prevention of certain chronic conditions and hence the consumption of these products has significantly increased over the past few years. For instance, nutraceuticals, such as omega-3 fatty acids, help in the prevention of cardiovascular conditions and the heightened accessibility to these low-cost vitamin supplements has reduced the incidences of vitamin deficiencies. 

In 2015, the gelatin capsules segment accounted for the highest revenue of nearly USD 1,172.3 million. This high revenue share is attributed to the following factors: sufficient availability of gelatin for the production process and the cost-effectiveness of gelatin capsules as compared to non-gelatin capsules, such as Hydroxypropyl methylcellulose (HPMC) capsules and pullulan or starch material capsules. 

However, the non-gelatin capsules segment is expected to emerge as the fastest growing category with a CAGR of 6.9% from 2016 to 2024. With the source of the non-gelatin capsules being vegetarian, the religious and cultural issues experienced in connection with capsules containing animal-derived inactive ingredients can be evaded; this factor is estimated to be primarily responsible for the large consumer base of this market over the forecast period.  

Access Research Report of Empty Capsules Market @ www.grandviewresearch.com/industry-analysis/empty-capsules-market

Further key findings from the study suggest:

·       In 2015, the antibiotic and antibacterial drugs segment generated the largest revenue of USD 453.7 million owing to the surge in prevalence of a range of infectious diseases and chronic conditions worldwide. The vitamins and dietary supplements category is expected to exhibit the fastest growth rate of 7.8% over the forecast period.

·        Global efforts to reduce malnutrition and vitamin deficiencies by various social welfare organizations and government agencies are expected to boost the usage rates over the forecast period.

·       In 2015, North America dominated the empty capsules market with a revenue share of over 39.6% due to the high disease burden, the access to the latest drugs in this region, and the high consumption rate of nutraceutical and cosmeceutical products in this region. Increase in the geriatric population susceptible to varied conditions and disorders coupled with the burgeoning of various bacterial and viral infections is expected to improve the market penetration of various antibiotics, multivitamin supplements, and other drugs.

·       The Asia Pacific region is estimated to grow with the highest CAGR of 7.9% over the forecast period. The increase in healthcare expenditure and the rise in per-capita disposable incomes are expected to improve the overall access to healthcare facilities and medicines across several developing countries in this region. Moreover, the upsurge in the prevalence of infectious diseases and chronic conditions in this region are also expected to positively reinforce the market growth over the forecast period.

·       The market dynamics indicate the presence of strong competition amongst the key players, such as Capsugel, Inc., ACG Associated capsules Pvt. Ltd., JC Biological Technology Co. Ltd, CapsCanada Corporation, Medicaps Ltd., Qualicaps, Inc. (Mitsubishi Chemical Holdings Corporation), Patheon, Inc. (Banner Pharmacaps, Inc.), Roxlor LLC, Sunil Healthcare Ltd.(Sunloc Healthcare, Inc.), and Nectar Lifesciences Ltd.

·       Furthermore, the increase in the demand for generic drugs and contract manufacturing services is expected to open up new avenues for the market growth over the forecast period. 

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the empty capsules market by product, therapeutic application, end user and region: 

Global empty capsules market, by product (USD Million, 2013 - 2024)

·         Gelatin Capsules

·         Non-Gelatin capsules

Global empty capsules market by therapeutic application (USD Million, 2013 - 2024)

·         Antibiotic and antibacterial drugs

·         Vitamin and dietary supplements

·         Antacids and antiflatulent preparations,

·         Antianemic preparations,

·         Anti-inflammatory and anti-rheumatic drugs,

·         Cardiac therapy drugs,

·         Cough and cold preparations

Global empty capsules market by end-user (USD Million, 2013 - 2024)

·         Pharmaceutical industries

·         Nutraceutical industries

·         Cosmeceutical industries

·         Research laboratories

Empty capsules market, by region (USD Million, 2013 - 2024)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         MEA

Access Press Release of Empty Capsules Market@ www.grandviewresearch.com/press-release/global-empty-capsules-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com